SEG Solar Announces First Section 45X Tax Credit Sale
HOUSTON, June 18, 2025 /PRNewswire/ -- SEG Solar ("SEG"), a leading U.S.-based PV module manufacturer, announced the successful completion of its first transaction for the sale of Section 45X Advanced Manufacturing Production Tax Credits, with a...
Industry-First! SpiroxLTS Reveals the True Quality of TGV Laser-Modified Vias Accelerating TGV Mass Production
HSINCHU, June 17, 2025 /PRNewswire/ -- Professional semiconductor equipment provider Spirox Corporation (TWSE: 3055) has introduced the industry-first SpiroxLTS (Spirox Laser Tomography Scanning) technology. Leveraging a combination of multiple...
Sobot Reveals "AI-First" Strategy for Delivering Human-like Customer Service
Reshaping AI-Powered Customer Service and CX with Five Pillars of Next-Gen AI NEW YORK, June 10, 2025 /PRNewswire/ -- Sobot, a leading AI customer contact solution provider, unveiled its "AI-First" strategy at a media launch event this month. The...
LG Innotek Unveils World's First Automotive 5G Broadband Satellite Communication Module
High-speed, high-volume communication anywhere, anytime—enhancing safety and advancing autonomous driving capabilities. "The core of LG Innotek's Automotive Components Business, aiming to grow the automotive communication module segment into...
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer
SAN FRANCISCO, and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Eye Level Awards 2025: First-Ever Joint Ceremony for Hong Kong & Macau Students
Multiple international competitions inspired students to aim higher, winning praise from educators and parents alike. HONG KONG, May 27, 2025 /PRNewswire/ -- The annual Eye Level Awards Ceremony cum Carnival 2025, organized by Daekyo Hong Kong, was...
Aker Horizons ASA: First-quarter results 2025
FORNEBU, Norway, May 8, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: AKH), a developer of green energy and industry, today announced results for the first quarter 2025. Aker Horizons' net capital employed stood at NOK 4.3 billion, a decrease of NOK...
Innovent Announces Oral Presentation of Full Phase 2 Clinical Data for Efdamrofusp Alfa (IBI302), First-in-class anti-VEGF/complement Bispecific Fusion Protein at ARVO 2025
SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...